Works matching IS 13889842 AND DT 2022 AND VI 24 AND IP 10

Results: 42

Inhibiting the proximal nephron in acute heart failure - emerging data on kidney safety and efficacy.
Published in:
2022
By:
- Martens, Pieter
Publication type:
Editorial
Can subgroup analyses in randomized trials guide individualized patient care?
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1802, doi. 10.1002/ejhf.2710
By:
- Aronson, Doron
Publication type:
Article
Random admission urinary sodium for diuretic response: promise in pragmatism?
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1988, doi. 10.1002/ejhf.2704
By:
- Chatur, Safia;
- Lakdawala, Neal K.;
- Cunningham, Jonathan W.
Publication type:
Article
Morphine in acute pulmonary oedema: a signal of harm but more questions than answers.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1963, doi. 10.1002/ejhf.2698
By:
- Chioncel, Ovidiu;
- Metra, Marco
Publication type:
Article
Iron repletion in heart failure: a central chemoreceptor reflex tonic?
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1950, doi. 10.1002/ejhf.2697
By:
- Keir, Daniel A.;
- Floras, John S.
Publication type:
Article
Glucagon‐like peptide 1 receptor agonists in heart failure: the need for a rewind.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1813, doi. 10.1002/ejhf.2693
By:
- Ferreira, João Pedro;
- Neves, João Sérgio
Publication type:
Article
Corrigendum to 'Use of evidence‐based therapy in heart failure with reduced ejection fraction across age strata' [Eur J Heart Fail 2022;24:1047–1062].
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1995, doi. 10.1002/ejhf.2691
Publication type:
Article
Reply to 'Particular challenges in the use of pulmonary vasodilating therapy for patients with pulmonary hypertension secondary to left heart disease'.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1990, doi. 10.1002/ejhf.2690
By:
- Cooper, Trond J.;
- Pellicori, Pierpaolo;
- Ushakova, Anastasia;
- Dickstein, Kenneth
Publication type:
Article
Multi‐biomarker approach to predict survival and adverse cardiovascular events among patients with heart failure with preserved ejection fraction.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1879, doi. 10.1002/ejhf.2689
By:
- Joury, Abdulaziz;
- Razaghizad, Amir;
- Sharma, Abhinav
Publication type:
Article
Sodium–glucose cotransporter 2 inhibitors for heart failure with mildly reduced or preserved ejection fraction: time to deliver implementation.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1902, doi. 10.1002/ejhf.2688
By:
- Greene, Stephen J.;
- Fonarow, Gregg C.;
- Butler, Javed
Publication type:
Article
Reply to 'Sodium–glucose cotransporter 2 inhibitor treatment lowers serum uric acid in patients with heart failure with reduced ejection fraction – lessons from clinical trials'.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1994, doi. 10.1002/ejhf.2686
By:
- McDowell, Kirsty;
- Jhund, Pardeep S;
- McMurray, John JV
Publication type:
Article
Patiromer use in patients with heart failure: lessons and clinical considerations from the DIAMOND trial.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1744, doi. 10.1002/ejhf.2684
By:
- Butler, Javed;
- Siddiqi, Tariq Jamal;
- Anker, Stefan D.
Publication type:
Article
Renal effects of empagliflozin in patients hospitalized for acute heart failure: from the EMPULSE trial.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1844, doi. 10.1002/ejhf.2681
By:
- Voors, Adriaan A.;
- Damman, Kevin;
- Teerlink, John R.;
- Angermann, Christiane E.;
- Collins, Sean P.;
- Kosiborod, Mikhail;
- Biegus, Jan;
- Ferreira, João Pedro;
- Nassif, Michael E.;
- Psotka, Mitchell A.;
- Tromp, Jasper;
- Brueckmann, Martina;
- Blatchford, Jonathan P.;
- Salsali, Afshin;
- Ponikowski, Piotr
Publication type:
Article
Heart failure outcomes according to heart rate and effects of empagliflozin in patients of the EMPEROR‐Preserved trial.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1883, doi. 10.1002/ejhf.2677
By:
- Böhm, Michael;
- Butler, Javed;
- Mahfoud, Felix;
- Filippatos, Gerasimos;
- Ferreira, João Pedro;
- Pocock, Stuart J.;
- Slawik, Jonathan;
- Brueckmann, Martina;
- Linetzky, Bruno;
- Schüler, Elke;
- Wanner, Christoph;
- Zannad, Faiez;
- Packer, Milton;
- Anker, Stefan D.
Publication type:
Article
Corrigendum to 'Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction' [Eur J Heart Fail 2022;24:782–790].
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1996, doi. 10.1002/ejhf.2676
Publication type:
Article
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1767, doi. 10.1002/ejhf.2675
By:
- Bayes‐Genis, Antoni;
- Aimo, Alberto;
- Jhund, Pardeep;
- Richards, Mark;
- de Boer, Rudolf A.;
- Arfsten, Henrike;
- Fabiani, Iacopo;
- Lupón, Josep;
- Anker, Stefan D.;
- González, Arantxa;
- Castiglione, Vincenzo;
- Metra, Marco;
- Mueller, Christian;
- Núñez, Julio;
- Rossignol, Patrick;
- Barison, Andrea;
- Butler, Javed;
- Teerlink, John;
- Filippatos, Gerasimos;
- Ponikowski, Piotr
Publication type:
Article
Worsening renal function precedes and follows worsening heart failure.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1915, doi. 10.1002/ejhf.2673
By:
- Girerd, Nicolas
Publication type:
Article
Cardiopulmonary functional capacity: another piece of the puzzle of sodium–glucose cotransporter 2 inhibition in heart failure?
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1827, doi. 10.1002/ejhf.2672
By:
- Jhund, Pardeep S.
Publication type:
Article
Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post‐hoc analysis from the REWIND randomized trial.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1805, doi. 10.1002/ejhf.2670
By:
- Branch, Kelley R.H.;
- Dagenais, Gilles R.;
- Avezum, Alvaro;
- Basile, Jan;
- Conget, Ignacio;
- Cushman, William C.;
- Jansky, Petr;
- Lakshmanan, Mark;
- Lanas, Fernando;
- Leiter, Lawrence A.;
- Pais, Prem;
- Pogosova, Nana;
- Raubenheimer, Peter J.;
- Ryden, Lars;
- Shaw, Jonathan E.;
- Sheu, Wayne H.H.;
- Temelkova‐Kurktschiev, Theodora;
- Bethel, M. Angelyn;
- Gerstein, Hertzel C.;
- Chinthanie, Ramasundarahettige
Publication type:
Article
Sodium–glucose cotransporter 2 inhibitor treatment lowers serum uric acid in patients with heart failure with reduced ejection fraction – lessons from clinical trials. Letter regarding the article 'Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA‐HF'
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1993, doi. 10.1002/ejhf.2666
By:
- Doehner, Wolfram;
- Packer, Milton
Publication type:
Article
Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1751, doi. 10.1002/ejhf.2664
By:
- Núñez, Julio;
- de la Espriella, Rafael;
- Rossignol, Patrick;
- Voors, Adriaan A.;
- Mullens, Wilfried;
- Metra, Marco;
- Chioncel, Ovidiu;
- Januzzi, James L.;
- Mueller, Christian;
- Richards, A. Mark;
- de Boer, Rudolf A.;
- Thum, Thomas;
- Arfsten, Henrike;
- González, Arantxa;
- Abdelhamid, Magdy;
- Adamopoulos, Stamatis;
- Anker, Stefan D.;
- Gal, Tuvia Ben;
- Biegus, Jan;
- Cohen‐Solal, Alain
Publication type:
Article
Sacubitril/valsartan versus ramipril for patients with acute myocardial infarction: win‐ratio analysis of the PARADISE‐MI trial.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1918, doi. 10.1002/ejhf.2663
By:
- Berwanger, Otavio;
- Pfeffer, Marc;
- Claggett, Brian;
- Jering, Karola S.;
- Maggioni, Aldo P.;
- Steg, Philippe Gabriel;
- Mehran, Roxana;
- Lewis, Eldrin F.;
- Zhou, Yinong;
- van der Meer, Peter;
- De Pasquale, Carmine;
- Merkely, Béla;
- Filippatos, Gerasimos;
- McMurray, John J.V.;
- Granger, Christopher B.;
- Solomon, Scott D.;
- Braunwald, Eugene
Publication type:
Article
Assessing intrinsic renal sodium avidity in acute heart failure: implications in predicting and guiding decongestion.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1978, doi. 10.1002/ejhf.2662
By:
- Martens, Pieter;
- Chen, Horng H.;
- Verbrugge, Frederik H.;
- Testani, Jeffrey T.;
- Mullens, Wilfried;
- Tang, W.H. Wilson
Publication type:
Article
Albiglutide in patients with type 2 diabetes and heart failure: a post‐hoc analysis from Harmony Outcomes.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1792, doi. 10.1002/ejhf.2660
By:
- Ferreira, João Pedro;
- Sharma, Abhinav;
- Vasques‐Nóvoa, Francisco;
- Angélico‐Gonçalves, António;
- Leite, Ana Rita;
- Borges‐Canha, Marta;
- Carvalho, Davide;
- Packer, Milton;
- Zannad, Faiez;
- Leite‐Moreira, Adelino;
- Neves, João Sérgio
Publication type:
Article
Early changes in renal function after sodium–glucose cotransporter 2 inhibitor initiation in EMPEROR‐Reduced: the end of the dilemma?
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1840, doi. 10.1002/ejhf.2659
By:
- Beldhuis, Iris E.;
- Martens, Pieter;
- ter Maaten, Jozine M.
Publication type:
Article
Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1892, doi. 10.1002/ejhf.2652
By:
- Ostrominski, John W.;
- Vaduganathan, Muthiah;
- Claggett, Brian L.;
- de Boer, Rudolf A.;
- Desai, Akshay S.;
- Dobreanu, Dan;
- Hernandez, Adrian F.;
- Inzucchi, Silvio E.;
- Jhund, Pardeep S.;
- Kosiborod, Mikhail;
- Lam, Carolyn S.P.;
- Langkilde, Anna M.;
- Lindholm, Daniel;
- Martinez, Felipe A.;
- O'Meara, Eileen;
- Petersson, Magnus;
- Shah, Sanjiv J.;
- Thierer, Jorge;
- McMurray, John J.V.;
- Solomon, Scott D.
Publication type:
Article
Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA‐HF.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1856, doi. 10.1002/ejhf.2649
By:
- Adamson, Carly;
- Cowan, Lorna M.;
- de Boer, Rudolf A.;
- Diez, Mirta;
- Drożdż, Jarosław;
- Dukát, Andre;
- Inzucchi, Silvio E.;
- Køber, Lars;
- Kosiborod, Mikhail N.;
- Ljungman, Charlotta E.A.;
- Martinez, Felipe A.;
- Ponikowski, Piotr;
- Sabatine, Marc S.;
- Lindholm, Daniel;
- Bengtsson, Olof;
- Boulton, David W.;
- Greasley, Peter J.;
- Langkilde, Anna Maria;
- Sjöstrand, Mikaela;
- Solomon, Scott D.
Publication type:
Article
Enrolling patients in cardiogenic shock trials: are we missing someone? Insights from the Italian AltShock‐2 registry.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1748, doi. 10.1002/ejhf.2640
By:
- Pappalardo, Federico;
- Tavazzi, Guido;
- Savonitto, Stefano;
- Morici, Nuccia
Publication type:
Article
Longitudinal trajectories in renal function before and after heart failure hospitalization among patients with heart failure with preserved ejection fraction in the PARAGON-HF trial.
Published in:
2022
By:
- Chatur, Safia;
- Vaduganathan, Muthiah;
- Peikert, Alexander;
- Claggett, Brian L.;
- McCausland, Finnian R.;
- Skali, Hicham;
- Pfeffer, Marc A.;
- Beldhuis, Iris E.;
- Kober, Lars;
- Seferovic, Petar;
- Lefkowitz, Martin;
- McMurray, John J.V.;
- Solomon, Scott D.
Publication type:
journal article
Accelerating cardiovascular research: recent advances in translational 2D and 3D heart models.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1778, doi. 10.1002/ejhf.2631
By:
- Mohr, Elisa;
- Thum, Thomas;
- Bär, Christian
Publication type:
Article
Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM‐AHF trial.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1928, doi. 10.1002/ejhf.2630
By:
- Metra, Marco;
- Jankowska, Ewa A.;
- Pagnesi, Matteo;
- Anker, Stefan D.;
- Butler, Javed;
- Dorigotti, Fabio;
- Fabien, Vincent;
- Filippatos, Gerasimos;
- Kirwan, Bridget‐Anne;
- Macdougall, Iain C.;
- Rosano, Giuseppe;
- Ruschitzka, Frank;
- Tomasoni, Daniela;
- van der Meer, Peter;
- Ponikowski, Piotr
Publication type:
Article
Safety and efficacy of istaroxime in patients with acute heart failure‐related pre‐cardiogenic shock – a multicentre, randomized, double‐blind, placebo‐controlled, parallel group study (SEISMiC).
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1967, doi. 10.1002/ejhf.2629
By:
- Metra, Marco;
- Chioncel, Ovidiu;
- Cotter, Gad;
- Davison, Beth;
- Filippatos, Gerasimos;
- Mebazaa, Alexandre;
- Novosadova, Maria;
- Ponikowski, Piotr;
- Simmons, Phillip;
- Soffer, Joseph;
- Simonson, Steven
Publication type:
Article
Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1940, doi. 10.1002/ejhf.2628
By:
- Caravita, Sergio;
- Faini, Andrea;
- Vignati, Carlo;
- Pelucchi, Sara;
- Salvioni, Elisabetta;
- Cattadori, Gaia;
- Baratto, Claudia;
- Torlasco, Camilla;
- Contini, Mauro;
- Villani, Alessandra;
- Malfatto, Gabriella;
- Perger, Elisa;
- Lombardi, Carolina;
- Piperno, Alberto;
- Agostoni, Piergiuseppe;
- Parati, Gianfranco
Publication type:
Article
Reply to the letter regarding the article 'Cardiac energetics in patients with chronic heart failure and iron deficiency: an in‐vivo31P magnetic resonance spectroscopy study'.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1992, doi. 10.1002/ejhf.2625
By:
- Papalia, Francesco;
- Charles‐Edwards, Geoffrey;
- Okonko, Darlington O.
Publication type:
Article
Particular challenges in the use of pulmonary vasodilating therapy for patients with pulmonary hypertension secondary to left heart disease. Letter regarding the article ′Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomized placebo‐controlled multicentre trial'
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1990, doi. 10.1002/ejhf.2622
By:
- Dandel, Michael;
- Hetzer, Roland
Publication type:
Article
Biomarker‐driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR–Preserved trial.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1869, doi. 10.1002/ejhf.2607
By:
- Pocock, Stuart J.;
- Ferreira, João Pedro;
- Packer, Milton;
- Zannad, Faiez;
- Filippatos, Gerasimos;
- Kondo, Toru;
- McMurray, John J.V.;
- Solomon, Scott D.;
- Januzzi, James L.;
- Iwata, Tomoko;
- Salsali, Afshin;
- Butler, Javed;
- Anker, Stefan D.
Publication type:
Article
October 2022 at a glance: focus on clinical trials.
Published in:
2022
By:
- Tomasoni, Daniela;
- Adamo, Marianna;
- Metra, Marco
Publication type:
journal article
Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Reduced.
Published in:
2022
By:
- Zannad, Faiez;
- Ferreira, João Pedro;
- Gregson, John;
- Kraus, Bettina Johanna;
- Mattheus, Michaela;
- Hauske, Sibylle Jenny;
- Butler, Javed;
- Filippatos, Gerasimos;
- Wanner, Christoph;
- Anker, Stefan D.;
- Pocock, Stuart J.;
- Packer, Milton;
- EMPEROR-Reduced Trial Committees and Investigators
Publication type:
journal article
Letter regarding the article 'Cardiac energetics in patients with chronic heart failure and iron deficiency: an in‐vivo31P magnetic resonance spectroscopy study'.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1992, doi. 10.1002/ejhf.2574
By:
- Burrage, Matthew K.;
- Valkovič, Ladislav;
- Rider, Oliver J.
Publication type:
Article
Short‐term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA‐VO2): a randomized clinical trial.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1816, doi. 10.1002/ejhf.2560
By:
- Palau, Patricia;
- Amiguet, Martina;
- Domínguez, Eloy;
- Sastre, Clara;
- Mollar, Anna;
- Seller, Julia;
- Garcia Pinilla, Jose Manuel;
- Larumbe, Ainoha;
- Valle, Alfonso;
- Gómez Doblas, Juan Jose;
- de la Espriella, Rafael;
- Miñana, Gema;
- Mezcua, Ainhoa Robles;
- Santas, Enrique;
- Bodí, Vicent;
- Sanchis, Juan;
- Pascual‐Figal, Domingo;
- Górriz, Jose Luis;
- Baýes‐Genís, Antonio;
- Núñez, Julio
Publication type:
Article
Issue Information.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. i, doi. 10.1002/ejhf.2425
Publication type:
Article
Midazolam versus morphine in acute cardiogenic pulmonary oedema: results of a multicentre, open-label, randomized controlled trial.
Published in:
2022
By:
- Domínguez‐Rodríguez, Alberto;
- Suero‐Mendez, Coral;
- Burillo‐Putze, Guillermo;
- Gil, Victor;
- Calvo‐Rodriguez, Rafael;
- Piñera‐Salmeron, Pascual;
- Llorens, Pere;
- Martín‐Sánchez, Francisco J.;
- Abreu‐Gonzalez, Pedro;
- Miró, Òscar;
- Bredy, Clara Gironés;
- Lozano, Miguel Benito;
- Hernández, María Ángeles López;
- Ramos, Iván Hernández;
- Sánchez, Agustina Jurado;
- Díaz, Aceysele Gonzalez;
- Martín, Elena Porcel;
- Cid, Darío Giménez;
- Bellido, María Cabra;
- Ruiz, Ana Pérez
Publication type:
journal article